Skip to content

Risk Factors for Pregnancy-induced Hypertension in Pregnant Patients Undergoing Cesarean Section

Risk Factors for Pregnancy-induced Hypertension in Pregnant Patients Undergoing Cesarean Section: a Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04808375
Enrollment
1200
Registered
2021-03-22
Start date
2021-03-30
Completion date
2023-03-30
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Maternal and Neonatal Outcomes

Brief summary

After Institutional Review Board approval, we performed a retrospective cohort study among all women presenting for pregnancy-induced hypertension under Cesarean section in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020.Perioperative data were collected, including preoperative general condition, laboratory examination, auxiliary examination (blood routine, blood coagulation, liver and kidney function, electrocardiogram, cardiac ultrasound, etc.), perioperative indicators, postoperative laboratory examination (blood routine, blood coagulation, liver and kidney function, etc.), postoperative follow-up and satisfaction survey of patients.

Interventions

None listed

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* all women presenting for pregnancy-induced hypertension in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020 cesarean section operation

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
Adverse maternal outcomes42 days after deliveryAdverse maternal outcomes were evaluated individually and as a composite and included number of acute kidney injury (serum creatinine \>1.1 mg/dL or oliguria), number of blood transfusion, number of eclampsia, rate of intensive care unit (ICU) admission, number of postpartum hemorrhage, or pulmonary edema.(From date of randomization until the date of discharged from hospital, whichever came first, assessed up to 40 weeks).
Adverse neonatal outcomes42 days after deliveryNumber of neonatal outcomes included preterm birth (PTB; \<37 weeks), Number of neonatal ICU (NICU) admission, number of neonatal intubation, and number of respiratory distress syndrome.(From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 40weeks).(From the date of birth until the date of discharged from hospital, whichever came first, assessed up to 5 weeks).

Countries

China

Contacts

Primary ContactDan Huang, M.S.
huangdan363@163.com+8615921108822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026